Skip to content

Anthony Levitt

4 papers in the library · publishing 2018-2026

Papers

Sort Most recent Most cited

A Brief Intervention for the Treatment of Anxiety in Pregnancy: A Pilot Randomized Controlled Trial (The TAP Study).

Psychotherapy and Psychosomatics March 30, 2026 Sophie Grigoriadis, Neeti Sharma, Cindy-Lee Dennis et al.

Anxiety during pregnancy affects 1 in 4 pregnancies and is often comorbid with other mental health disorders. Early intervention is crucial to avoid persistent mental health issues and adverse obstetrical, neonatal and child outcomes. Traditional mindfulness-based cognitive therapy is effective, but its uptake is limited by its high resource intensity for patients and healthcare services. This...

Proof-of-concept randomized controlled trial of single-session nitrous oxide treatment for refractory bipolar depression: Focus on cerebrovascular target engagement.

Bipolar Disorders May 1, 2023 William S H Kim, Mikaela K Dimick, Danielle Omrin et al.

There remain few efficacious treatments for bipolar depression, which dominates the course of bipolar disorder (BD). Despite multiple studies reporting associations between depression and cerebral blood flow (CBF), little is known regarding CBF as a treatment target, or predictor and/or indicator of treatment response, in BD. Nitrous oxide, an anesthetic gas with vasoactive and putative...

DOI: 10.1111/bdi.13288 (opens in new tab) Full text (opens in new tab) Arterial spin labeling Bipolar depression Bipolar disorder Cerebral blood flow +2

Nitrous oxide as a putative novel dual-mechanism treatment for bipolar depression: Proof-of-concept study design and methodology.

Contemporary Clinical Trials Communications September 1, 2020 Mikaela K Dimick, Danielle Omrin, Bradley J MacIntosh et al.

Depressive symptoms predominate in the course of bipolar disorder (BD) and there is an urgent need to evaluate novel application of repurposed compounds that act on pre-specified treatment targets. Several lines of reasoning suggest that nitrous oxide (N2O) is an ideal medication to study as a potential treatment and as a strategy to identify the underlying pathophysiology of bipolar...

DOI: 10.1016/j.conctc.2020.100600 (opens in new tab) Full text (opens in new tab) Bipolar depression Cerebral blood flow Nitrous oxide Novel therapeutics

Ketamine augmentation for major depressive disorder and suicidal ideation: Preliminary experience in an inpatient psychiatry setting.

Journal of Affective Disorders December 1, 2018 Mark Sinyor, Marissa Williams, Sue Belo et al.

Ketamine is known to rapidly reduce depressive symptoms and suicidal ideation (SI) in patients with major depressive disorder (MDD), but evidence is limited for its acceptability and effectiveness in "real-world" settings. This case series examines serial ketamine infusions in reducing SI and depression scores in adults with MDD admitted to a tertiary care hospital. Five inpatients with MDD and...